drugset / Trial / NCT00501865

Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers

NCT00501865

Phase 1 Completed 14 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelDiagnostic

Summary

The rationale of this study is to assess whether or not food affects the absorption of GW273225 into the blood of healthy male and female volunteers in order to evaluate whether or not this drug should be given at a certain time relative to the consumption of food.

Timeline

Start
2007-08-06
Primary completion
2007-10-11
Completion
2007-10-11

Drugs

EvaluationDrugModalityDoseRoute
Subject GW273225 Unknown 50 mg Oral

Indications